植耀辉: 疫情冲击美股续捱沽 港股看22,500点支持
耀才证券研究部总监植耀辉称,投资者继续关注疫情消息,受到当地感染人数大幅攀升,隔晚(4月1日)美国三大指数再度急挫,道指大跌973点或4.44%,收报20,943点;标普500指数则跌114点或4.41%,收报2,470点;纳指亦跌339点或4.41%,收报7,360点。截至执笔一刻为止,美国感染人数已突破20万,全球感染人数亦已超过92万。对经济以至民生的冲击实在难以估算。
港股在踏入第二季後首个交易日表现疲弱,外围疫情状况极不明朗,加上汇丰控股(00005.HK)及渣打集团(02888.HK)突然宣布停止派发股息,令金融股显着受压,事实上,单是一只汇控,已令恒指大跌210点!当然,午市後道期又再急跌,令恒指跌势进一步加剧。但无可否认,困扰市场两大因素,包括疫情持续蔓延以及经济衰退阴霾,未来一段时间仍会影响大市去向。至於恒指短期表现,暂且看22,500点是否能有支持。
(笔者为证监会持牌人,并未持有相关股份)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.